Background: Underrecognition and undertreatment of depression in primary care has been regarded as a major public health problem. In contrast, some studies found that among patients labeled as depressed by primary-care physicians (PCPs), a relevant proportion do not satisfy international diagnostic criteria for depression. The aims of this study are: (1) to assess disparity between PCP diagnosis and research diagnosis of depression; (2) to compare antidepressant treatment in concordant and discordant cases of depression. Methods: Data are gathered from a national survey on depressive disorders in primary care, conducted with the collaboration of 191 PCPs. Three hundred and sixty-one PCP patients were evaluated, and their psychiatric diagnosis was established by the ‘unaided’ PCPs and by using a research interview for depression. Results: PCPs recognized 79.4% of cases of depression and prescribed antidepressants to 40.9% of them. Yet, 45.0% of patients labeled as depressed by the PCPs were not cases of depression according to ICD-10 criteria; 26.9% of false-positive cases received an antidepressant. Globally, 35% of antidepressants for ‘depression’ were prescribed to false-positive cases. Conclusions: Underrecognition and undertreatment of depression in primary care seem to be less alarming. Conversely, PCP diagnoses of depression appear to be more inclusive than psychiatric diagnostic criteria. A possible consequence of this apparently more inclusive diagnostic threshold may be an excessive use of antidepressants. These changes require a corresponding change in research, toward efficacy and safety of the treatment of milder cases, and in education, toward the distinction between the management of mild and severe cases of depression.

Keywords:
Primary health care, Depressive disorder, Epidemiology, Antidepressive agents
1.
Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Marek RG, Maurer TA, Meyer R, Phillips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ: The national depressive and manic-depressive association consensus statement on undertreatment of depression. JAMA 1997;277:333–340.
2.
Blacker CV, Clare AW: Depressive disorder in primary care. Br J Psychiatry 1987;150:737–751.
3.
Goldman LS, Nielsen NH, Champion HC: Awareness, diagnosis, and treatment of depression. J Gen Intern Med 1999;14:569–580.
4.
Wells KB, Katon W, Rogers B, Camp P: Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the medical outcomes study. Am J Psychiatry 1994;151:694–700.
5.
Üstün TB, Von Korff M: Primary mental health services: Access and provision of care; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley & Sons, 1995, pp 349–375.
6.
Hodges B, Inch C, Silver I: Improving the psychiatric knowledge, skills, and attitudes of primary care physicians, 1950–2000: A review. Am J Psychiatry 2001;158:1579–1586.
7.
Gerber PD, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R: Recognition of depression by internists in primary care: A comparison of internist and ‘gold standard’ psychiatric assessments. J Gen Intern Med 1989;4:7–13.
8.
Perez-Stable EJ, Miranda J, Munoz RF, Ying YW: Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Intern Med 1990;150:1083–1088.
9.
Klinkman MS, Coyne JC, Gallo S, Schwenk TL: False positives, false negatives, and the validity of the diagnosis of major depression in primary care. Arch Fam Med 1998;7:451–461.
10.
Tiemens BG, Von Korff M, Lin EHB: Diagnosis of depression by primary care physicians versus a structured diagnostic interview. Gen Hosp Psychiatry 1999;21:87–96.
11.
Wittchen HU, Hofler M, Meister W: Prevalence and recognition of depressive syndromes in German primary care settings: Poorly recognized and treated? Int Clin Psychopharmacol 2001;16:121–135.
12.
Berardi D, Leggieri G, Berti Ceroni G, Rucci P, Pezzoli A, Paltrinieri E, Grazian N, Ferrari G: Depression, disability and primary health care utilization: A nationwide epidemiological survey. Fam Pract 2002;19:397–400.
13.
Von Korff M, Üstün TB: Methods of the WHO Collaborative Study on ‘Psychological Problems in General Health Care’; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley & Sons, 1995, pp 19–38.
14.
Diagnostic and Management Guidelines for Mental Disorders in Primary Care, ICD-10 Chapter V Primary Care Version. Göttingen, WHO/Hogrefe & Huber, 1996.
15.
Janca A, Üstün TB, Early TS, Sartorius N: The ICD-10 symptom checklist: A comparison to the ICD-10 classification of mental and behavioral disorders. Soc Psychiatry Psychiatr Epidemiol 1993;28:239–242.
16.
Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, Kathol R: Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996;53:880–886.
17.
Bellantuono C, Mazzi MA, Tansella M, Rizzo R, Goldberg D: The identification of depression and the coverage of antidepressant drug prescriptions in Italian general practice. J Affect Disord 2002;72:53–59.
18.
Piccinelli M, Pini S, Bonizzato P, Paltrinieri E, Saltini A, Scantamburlo L, Bellantuono C, Tansella M: Results from the Verona Centre; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley & Sons, 1995, pp 301–321.
19.
Olfson M, Marcus S, Druss B, Elinson L, Tanielian T, Pincus HA: National trends in the outpatient treatment of depression. JAMA 2002;287:203–209.
20.
Carta MG, Hardoy MC, Cadeddu M, Mura G, Floris AL, Carpiniello B: Psychotropic drug use in a sample of general population in the Sardinia region. Epidemiol Psichiatr Soc 2003;12:287–292.
21.
Goldberg D: Plato versus Aristoteles: Categorical and dimensional models for common mental disorders. Compr Psychiatry 2000;41(suppl 1):8–13.
22.
Pincus HA, Davis WW, McQueen LE: ‘Subthreshold’ mental disorders: A review and synthesis of studies on minor depression and other ‘brand names’. Br J Psychiatry 1999;174:288–296.
23.
Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, Corsino MA, Pini S: Subthreshold psychiatric disorders in primary care: Prevalence and associated characteristics. J Affect Disord 2003;76:171–181.
24.
Simon GE, Von Korff M: Recognition, management, and outcomes of depression in primary care. Arch Fam Med 1995;4:99–105.
25.
Ackerman RT, Williams JW Jr: Rational treatment choices for non-major depressions in primary care: An evidence-based review. J Gen Intern Med 2002;17:293–301.
26.
Simon GE: Evidence review: Efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry 2002;24:213–224.
27.
Bahl S, Cotterchio M, Krieger N: Use of antidepressant medications and the possible association with breast cancer risk. Psychother Psychosom 2003;72:185–194.
28.
Healy D: Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom 2003;72:71–79.
29.
Byrne SE, Rothschild AJ: Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments. J Clin Psychiatry 1998;59:279–288.
30.
Fava GA: Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry 2003;64:123–133.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.